Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese …

K Matsumoto, K Oda, K Shoji, Y Hanai, Y Takahashi… - Pharmaceutics, 2022 - mdpi.com
Background: To promote model-informed precision dosing (MIPD) for vancomycin (VCM),
we developed statements for therapeutic drug monitoring (TDM). Methods: Ten clinical …

[PDF][PDF] The use of vancomycin with its therapeutic and adverse effects: a review.

FR Bruniera, FM Ferreira, LRM Saviolli… - European Review for …, 2015 - europeanreview.org
RESULTS: The main adverse effects of vancomycin are: hypotension, phlebitis,
nephrotoxicity, ototoxicity, hypersensitivity reactions, red man syndrome, neutropenia, chills …

Are vancomycin trough concentrations adequate for optimal dosing?

MN Neely, G Youn, B Jones, RW Jelliffe… - Antimicrobial agents …, 2014 - Am Soc Microbiol
The current vancomycin therapeutic guidelines recommend the use of only trough
concentrations to manage the dosing of adults with Staphylococcus aureus infections. Both …

Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of …

K Matsumoto, Y Takesue, N Ohmagari… - Journal of Infection and …, 2013 - Springer
Methods Clinical practice guidelines for TDM of VCM were reviewed by a practice guideline
committee that consisted of 18 experts in TDM convened from the JSC and the JSTDM. The …

Association between vancomycin trough concentration and area under the concentration-time curve in neonates

A Frymoyer, AL Hersh, MH El-Komy… - Antimicrobial agents …, 2014 - Am Soc Microbiol
National treatment guidelines for invasive methicillin-resistant Staphylococcus aureus
(MRSA) infections recommend targeting a vancomycin 24-h area under the concentration …

Making the change to area under the curve–based vancomycin dosing

EL Heil, KC Claeys, RP Mynatt… - American Journal of …, 2018 - academic.oup.com
Vancomycin, a glycopeptide antimicrobial, is commonly employed for empirical and
definitive treatment of infections due to resistant gram-positive pathogens, notably methicillin …

The dosing and monitoring of vancomycin: what is the best way forward?

PG Drennan, EJ Begg, SJ Gardiner… - International journal of …, 2019 - Elsevier
We have evaluated the literature to review optimal dosing and monitoring of intravenous
vancomycin in adults, in response to evolving understanding of targets associated with …

Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond

NE Holmes, SYC Tong, JS Davis… - Seminars in respiratory …, 2015 - thieme-connect.com
There has been a welcome increase in the number of agents available for the treatment of
methicillin-resistant Staphylococcus aureus (MRSA). Vancomycin remains an acceptable …

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy

TW Felton, JA Roberts, TP Lodise… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Piperacillin-tazobactam is frequently used for empirical and targeted therapy of infections in
critically ill patients. Considerable pharmacokinetic (PK) variability is observed in critically ill …

Pharmacokinetics/pharmacodynamics of β-lactams and therapeutic drug monitoring: from theory to practical issues in the intensive care unit

P Williams, MO Cotta, JA Roberts - Seminars in Respiratory and …, 2019 - thieme-connect.com
Despite therapeutic advances over recent decades, the mortality rate for sepsis and septic
shock is still approximately 25% worldwide. Early administration of appropriate intravenous …